XML 278 R68.htm IDEA: XBRL DOCUMENT v3.25.4
Segment Information (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2025
Dec. 31, 2024
Segment Information    
Summary of key metrics for evaluating performance of company

For the Three Months ended

September 30,

  ​ ​ ​

2025

  ​ ​ ​

2024

Research and development costs

$

3,361,858

$

1,248,189

General and administrative expenses

 

4,749,399

 

1,125,121

Other significant non-cash items:

 

  ​

 

  ​

Depreciation and amortization

 

287,095

 

316,711

Total Operating Expenses

$

(8,398,352)

$

(2,690,021)

For the Nine Months ended

September 30,

  ​ ​ ​

2025

  ​ ​ ​

2024

Research and development costs

$

6,211,043

$

3,755,549

General and administrative expenses

 

11,569,376

 

3,546,510

Other significant non-cash items:

 

  ​

 

  ​

Depreciation and amortization

 

665,832

 

1,015,118

Total Operating Expenses

$

(18,446,251)

$

(8,317,177)

For the year ended

December 31,

  ​ ​ ​

2024

  ​ ​ ​

2023

Research and development costs

$

5,176,932

$

7,152,913

General and administrative expenses

 

4,168,576

 

5,274,603

Other significant non-cash items:

 

  ​

 

  ​

Depreciation and amortization

 

1,256,391

 

1,829,997

Total Operating Expenses

 

10,601,899

 

14,257,513

Revenue

 

248,357

 

18,614

Total other items

 

(1,110,903)

 

74,792

Income tax (expense) benefit

 

(20,965)

 

356,437

Net loss

$

(11,485,410)

$

(13,807,670)